Agios Pharmaceuticals (AGIO) FCF Margin (QoQ) (2012 - 2026)
Agios Pharmaceuticals (AGIO) FCF Margin (QoQ) (2012 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,533.00 |
| Dec 31, 2025 | 19,268.00 |
| Sep 30, 2025 | -4,802.00 |
| Jun 30, 2025 | 66,020.00 |
| Mar 31, 2025 | -3,024.00 |
| Dec 31, 2024 | -31,648.00 |
| Sep 30, 2024 | -9,665.00 |
| Jun 30, 2024 | 37,645.00 |
| Mar 31, 2024 | -18,513.00 |
| Dec 31, 2023 | -20,116.00 |
| Sep 30, 2023 | 15,537.00 |
| Jun 30, 2023 | 71,548.00 |
| Mar 31, 2023 | -27,594.00 |
| Dec 31, 2022 | 73,648.00 |
| Sep 30, 2022 | -88,486.00 |
| Jun 30, 2022 | 1.08 Mn |
| Dec 31, 2020 | 35,546.00 |
| Sep 30, 2020 | -25,395.00 |
| Jun 30, 2020 | 4,954.00 |
| Mar 31, 2020 | 13,642.00 |